---
subject: 'F102'
session: 'NOVEMBER'
year: '2021'
paper: '1'
question: 'Q8'
chapters:
source_type: 'exam'
time_allocated_minutes: '32.4'
---

## QUESTION 8

An established mid-sized life insurer writes mainly group life business and a small amount of conventional whole life products (with no surrender value) to middle- and high-income individuals.

i. Outline briefly a method that could be used by the insurer to determine its liability for the whole life
products using a gross premium valuation method on a market-consistent basis.
[4]

The insurer performs a comprehensive mortality investigation every three years.
ii. Describe how the insurer would perform the mortality investigation.
[4]

A global pandemic has impacted the country for the past year, resulting in a higher-than-usual number of deaths.
It is expected that the pandemic will last for several more years before most of the population will be immunised.
Death rates from the pandemic vary by region, depending on vaccination rates and other factors.
iii. Outline how future monitoring of mortality experience might change due to the pandemic.
[2]

The mortality investigation just completed by the insurer has shown that mortality experience over the last year has been higher than previously expected for both products, with the most significant difference seen in the group life product. The insurer is about to calculate its insurance liabilities.
iv. Explain the likely impact of the pandemic on the liabilities to be calculated for the group life and whole life
products.
[4]

v. Outline 3 possible actions that the insurer may take in response to the increase in mortality experience due
to the pandemic.
[4]

**[Total 18]**


